Fresenius Medical Care AG & Co KGaA (FMS):医療機器:M&Aディール及び事業提携情報

◆英語タイトル:Fresenius Medical Care AG & Co KGaA (FMS) - Medical Equipment - Deals and Alliances Profile
◆商品コード:DATA904C7419
◆発行会社(調査会社):GlobalData
◆発行日:2018年10月
◆ページ数:65
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:ドイツ
◆産業分野:医療機器
◆販売価格オプション(消費税別)
Single User(1名様閲覧用)USD250 ⇒換算¥37,000見積依頼/購入/質問フォーム
Site License(同一事業所内共有可)USD500 ⇒換算¥74,000見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD750 ⇒換算¥111,000見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalData社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
GlobalData社の概要はこちらでご確認いただけます。



【レポートの概要】

Summary
Fresenius Medical Care AG & Co KGaA (Fresenius Medical), a subsidiary of Fresenius SE & Co KGaA, is an integrated dialysis company. It is one of the largest kidney dialysis companies in the world. It provides dialysis care services and products to individuals with chronic kidney failure. It develops and manufactures a comprehensive range of dialysis machines, systems and disposable products. The company also offers Care Coordination services including pharmacy services, vascular, cardiovascular and endovascular specialty services, non-dialysis laboratory testing services, physician services, hospitalist and intensivist services, health plan services and urgent care services. The company provides dialysis treatment at its clinics and also sells its products to other dialysis service providers. It conducts its operations through its subsidiaries in Europe, the Middle East, Africa, the Americas and Asia-Pacific. Fresenius Medical is headquartered in Bad Homburg, Germany.

Fresenius Medical Care AG & Co KGaA (FMS) – Medical Equipment – Deals and Alliances Profile provides you comprehensive data and trend analysis of the company’s Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.

GlobalData derived the data presented in this report from proprietary in-house Medical eTrack deals database, and primary and secondary research.

Scope

- Financial Deals – Analysis of the company’s financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.
- Deals by Year – Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.
- Deals by Type – Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.
- Deals by Region – Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.
- Deals by Sub-sector – Chart and table showing information on the number of deals and value reported by the company, by sub-sector.
- Major Deals – Information on the company’s major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company’s (major public companies) key financial metrics and ratios.
- Business Description – A brief description of the company’s operations.
- Key Employees – A list of the key executives of the company.
- Important Locations and Subsidiaries – A list and contact details of key centers of operation and subsidiaries of the company.
- Key Competitors – A list of the key competitors of the company.
- Key Recent Developments – A brief on recent news about the company.

Reasons to Buy

Get detailed information on the company’s financial deals that enable you to understand the company’s expansion/divestiture and fund requirements
- The profile enables you to analyze the company’s financial deals by region, by year, by business segments and by type, for a five year period.

Understand the company’s business segments’ expansion / divestiture strategy
- The profile presents deals from the company’s core business segments’ perspective to help you understand its corporate strategy.

Access elaborate information on the company’s recent financial deals that enable you to understand the key deals which have shaped the company
- Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company’s key financial metrics and ratios.

Equip yourself with detailed information about the company’s operations to identify potential customers and suppliers.
- The profile analyzes the company’s business structure, locations and subsidiaries, key executives and key competitors.

Stay up-to-date on the major developments affecting the company
- Recent developments concerning the company presented in the profile help you track important events.

Gain key insights into the company for academic or business research
- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.

Note*: Some sections may be missing if data is unavailable for the company.

【レポートの目次】

Table of Contents
Table of Contents 3
List of Tables 5
List of Figures 5
Fresenius Medical Care AG & Co KGaA, Medical Equipment, Deals By Year, 2012 to YTD 2018 6
Fresenius Medical Care AG & Co KGaA, Medical Equipment Deals By Type, 2012 to YTD 2018 7
Fresenius Medical Care AG & Co KGaA, Medical Equipment, Deals By Region, 2012 to YTD 2018 8
Fresenius Medical Care AG & Co KGaA, Medical Equipment, Deals By Market, 2012 to YTD 2018 9
Fresenius Medical Care AG & Co KGaA, Medical Equipment, Deals Summary, 2012 to YTD 2018 10
Fresenius Medical Care AG & Co KGaA, Medical Equipment, Deal Details 12
Venture Financing 12
Diabetes Care Group Secures USD0.2 Million in Seed Funding from TriStar Technology Ventures 12
Partnerships 13
Fresenius Medical Care and Humacyte Enter into Partnership Agreement 13
RenalSense Enters into Distribution Agreement with Fresenius Medical Care 14
Debiotech and Fresenius Medical Care Enter into Agreement 15
Sequana Medical Enters into Distribution Agreement with Fresenius Medical Care 16
Toray Industries Enters into Distribution Agreement with Fresenius Medical Care 17
JMS North America Enters Into Distribution Agreement With Fresenius Medical Care For AVF Needles 18
Equity Offering 19
Humacyte to Raise USD150 Million in Equity Financing 19
Debt Offering 20
Fresenius Medical Care Raises USD400 Million in Private Placement of 4.75% Notes Due 2024 20
Fresenius Medical Care Raises USD500 Million in Private Placement of 4.125% Notes Due 2020 21
Fresenius Medical Care Raises USD518 Million in Private Placement of Convertible Bonds 22
Fresenius Medical Care Prices Private Placement Of Notes Due 2020 For US$673 Million 23
Fresenius Medical Care Completes Private Placement Of 5.625% Senior Unsecured Notes Due 2019 For US$800 Million 25
Fresenius Medical Care Completes Private Placement Of 5.25% Senior Unsecured Notes Due 2019 For US$316.4 Million 26
Fresenius Medical Care Completes Private Placement Of 5.875% Senior Unsecured Notes Due 2022 For US$700 Million 27
Asset Transactions 28
Fresenius Medical to Divest Dialysis Services Unit in Venezuela 28
Fresenius Medical Care Divests Fresenius Medical care Dialysis Clinic for USD1.4 Million 29
Acquisition 30
Quest Diagnostics Acquires Shiel Medical from Fresenius Medical 30
Fresenius Medical Care to Acquire NxStage Medical for up to USD2 Billion 32
Fresenius Medical Care Acquires Xenios 34
Fresenius Medical Care AG & Co KGaA – Key Competitors 35
Fresenius Medical Care AG & Co KGaA – Key Employees 36
Fresenius Medical Care AG & Co KGaA – Locations And Subsidiaries 37
Head Office 37
Other Locations & Subsidiaries 37
Joint Venture 40
Recent Developments 41
Strategy And Business Planning 41
Nov 30, 2017: Fresenius Medical Care achieves a milestone in expanding its Asian operations 41
Financial Announcements 42
Jul 31, 2018: Fresenius Medical Care continues to grow in the second quarter and confirms outlook for 2018 42
Apr 22, 2018: Fresenius Medical Care confirms net income growth target, adjusts 2018 revenue growth target and releases preliminary Q1 figures 46
Feb 26, 2018: Fresenius Medical Care achieves record results in 2017 and targets strong net income growth in 2018 47
Nov 02, 2017: Fresenius Medical Care delivers solid Q3 despite impact from natural disasters in North America 50
Aug 01, 2017: Fresenius Medical Care delivers another quarter of strong revenue growth 53
May 03, 2017: Fresenius Medical Care delivers strong first quarter 2017 55
Feb 22, 2017: Fresenius Medical Care delivers strong 2016 results and sets ambitious growth targets for 2017 57
Legal and Regulatory 60
Feb 26, 2018: Fresenius Medical Care establishes provision of EUR 200 million regarding ongoing FCPA settlement negotiations 60
Jan 13, 2017: Statement of Fresenius Medical Care North America Regarding U.S. Court Ruling Granting Temporary Restraining Order 61
Government and Public Interest 62
Oct 08, 2018: Fresenius Medical Care supports access to hemodiafiltration for UK dialysis patients 62
Other Significant Developments 63
Apr 27, 2018: Fresenius Medical Care holds groundbreaking ceremony for new technology development center in Schweinfurt 63
Appendix 65
Methodology 65
About GlobalData 65
Contact Us 65
Disclaimer 65

List of Tables
Fresenius Medical Care AG & Co KGaA, Medical Equipment, Key Facts, 2017 2
Fresenius Medical Care AG & Co KGaA, Medical Equipment, Deals Summary, 2012 to YTD 2018 2
Fresenius Medical Care AG & Co KGaA, Medical Equipment, Deals By Year, 2012 to YTD 2018 6
Fresenius Medical Care AG & Co KGaA, Medical Equipment Deals By Type, 2012 to YTD 2018 7
Fresenius Medical Care AG & Co KGaA, Medical Equipment, Deals By Region, 2012 to YTD 2018 8
Fresenius Medical Care AG & Co KGaA, Deals By Market, 2012 to YTD 2018 9
Fresenius Medical Care AG & Co KGaA, Medical Equipment, Deals Summary, 2012 to YTD 2018 10
Diabetes Care Group Secures USD0.2 Million in Seed Funding from TriStar Technology Ventures 12
Fresenius Medical Care and Humacyte Enter into Partnership Agreement 13
RenalSense Enters into Distribution Agreement with Fresenius Medical Care 14
Debiotech and Fresenius Medical Care Enter into Agreement 15
Sequana Medical Enters into Distribution Agreement with Fresenius Medical Care 16
Toray Industries Enters into Distribution Agreement with Fresenius Medical Care 17
JMS North America Enters Into Distribution Agreement With Fresenius Medical Care For AVF Needles 18
Humacyte to Raise USD150 Million in Equity Financing 19
Fresenius Medical Care Raises USD400 Million in Private Placement of 4.75% Notes Due 2024 20
Fresenius Medical Care Raises USD500 Million in Private Placement of 4.125% Notes Due 2020 21
Fresenius Medical Care Raises USD518 Million in Private Placement of Convertible Bonds 22
Fresenius Medical Care Prices Private Placement Of Notes Due 2020 For US$673 Million 23
Fresenius Medical Care Completes Private Placement Of 5.625% Senior Unsecured Notes Due 2019 For US$800 Million 25
Fresenius Medical Care Completes Private Placement Of 5.25% Senior Unsecured Notes Due 2019 For US$316.4 Million 26
Fresenius Medical Care Completes Private Placement Of 5.875% Senior Unsecured Notes Due 2022 For US$700 Million 27
Fresenius Medical to Divest Dialysis Services Unit in Venezuela 28
Fresenius Medical Care Divests Fresenius Medical care Dialysis Clinic for USD1.4 Million 29
Quest Diagnostics Acquires Shiel Medical from Fresenius Medical 30
Fresenius Medical Care to Acquire NxStage Medical for up to USD2 Billion 32
Fresenius Medical Care Acquires Xenios 34
Fresenius Medical Care AG & Co KGaA, Key Competitors 35
Fresenius Medical Care AG & Co KGaA, Key Employees 36
Fresenius Medical Care AG & Co KGaA, Subsidiaries 37
Fresenius Medical Care AG & Co KGaA, Joint Venture 40

List of Figures
Fresenius Medical Care AG & Co KGaA, Medical Equipment, Deals by Type, 2012 to YTD 2018 2
Fresenius Medical Care AG & Co KGaA, Medical Equipment, Deals By Year, 2012 to YTD 2018 2
Fresenius Medical Care AG & Co KGaA, Medical Equipment, Deals By Region, 2012 to YTD 2018 2
Fresenius Medical Care AG & Co KGaA, Medical Equipment, Deals By Market, 2012 to YTD 2018 2
Fresenius Medical Care AG & Co KGaA, Medical Equipment, Deals By Year, 2012 to YTD 2018 6
Fresenius Medical Care AG & Co KGaA, Medical Equipment, Deals by Type, 2012 to YTD 2018 7
Fresenius Medical Care AG & Co KGaA, Medical Equipment, Deals By Region, 2012 to YTD 2018 8
Fresenius Medical Care AG & Co KGaA, Medical Equipment, Deals by Market, 2012 to YTD 2018 9

★海外企業調査レポート[Fresenius Medical Care AG & Co KGaA (FMS):医療機器:M&Aディール及び事業提携情報]についてメールでお問い合わせはこちら

■おすすめ企業レポート■
  • Linamar Corporation:企業の戦略・SWOT・財務情報
    Linamar Corporation - Strategy, SWOT and Corporate Finance Report Summary Linamar Corporation - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings a …
  • Yamato Holdings Co., Ltd.:企業の戦略・SWOT・財務情報
    Yamato Holdings Co., Ltd. - Strategy, SWOT and Corporate Finance Report Summary Yamato Holdings Co., Ltd. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service …
  • PT. Asuransi Jiwasraya (Persero):企業の戦略・SWOT・財務分析
    PT. Asuransi Jiwasraya (Persero) - Strategy, SWOT and Corporate Finance Report Summary PT. Asuransi Jiwasraya (Persero) - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, produ …
  • Arconic Inc (ARNC):企業の財務・戦略的SWOT分析
    Arconic Inc (ARNC) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and th …
  • TPG Telecom Ltd (TPM):企業の財務・戦略的SWOT分析
    TPG Telecom Ltd (TPM) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and …
  • Makita Corporation (6586):企業の財務・戦略的SWOT分析
    Makita Corporation (6586) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses …
  • Polynt SpA:企業の戦略的SWOT分析
    Polynt SpA - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and services. T …
  • Pacira BioSciences Inc (PCRX):企業の財務・戦略的SWOT分析
    Pacira BioSciences Inc (PCRX) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weakne …
  • Jitsubo Co Ltd:製薬・医療:M&Aディール及び事業提携情報
    Summary Jitsubo Co Ltd (Jitsubo), a subsidiary of Sosei Group Corp, is a biotechnology company that develops, manufactures and commercializes peptide therapeutics. The company’s molecular hiving technology modifies the polysaccharide and sugar chain peptide sequence. Its Molecular Hiving technology …
  • EnergySolutions, Inc.:企業の戦略・SWOT・財務情報
    EnergySolutions, Inc. - Strategy, SWOT and Corporate Finance Report Summary EnergySolutions, Inc. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerin …
  • Ossur hf (OSSR):企業の財務・戦略的SWOT分析
    Ossur hf (OSSR) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and the p …
  • DuluxGroup Ltd:企業の戦略・SWOT・財務情報
    DuluxGroup Ltd - Strategy, SWOT and Corporate Finance Report Summary DuluxGroup Ltd - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corpora …
  • Capstone Therapeutics Corp (CAPS)-製薬・医療分野:企業M&A・提携分析
    Summary Capstone Therapeutics Corp (Capstone), formerly OrthoLogic Corp is a biotechnology company that develops novel peptides and other molecules. The company develops novel peptides to support patients with under-served medical conditions. It develops AZX100 and Chrysalin drug platforms. Capstone …
  • W. R. Grace & Co:企業の戦略・SWOT・財務分析
    W. R. Grace & Co - Strategy, SWOT and Corporate Finance Report Summary W. R. Grace & Co - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and cor …
  • Bank Audi SAL:企業の戦略・SWOT・財務分析
    Bank Audi SAL - Strategy, SWOT and Corporate Finance Report Summary Bank Audi SAL - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate …
  • C3J Therapeutics Inc-製薬・医療分野:企業M&A・提携分析
    Summary C3J Therapeutics Inc (C3J), formerly C3 Jian Inc, is a clinical-stage biotechnology company which concentrates on the development and commercialization of targeted and pathogen specific, antimicrobials that treat and prevent diseases caused by microbial dysbiosis. Its pipeline product portfo …
  • Blueberry Therapeutics Ltd:製薬・医療:M&Aディール及び事業提携情報
    Summary Blueberry Therapeutics Ltd (Blueberry Therapeutics) is a provider of nano medicines for the treatment of dermatological disorders. Its pipeline product portfolio includes BB2603-NCE, developed to treat onychomycosis and associated tinea pedis; BB2312 used for the treatment of Acne diseases, …
  • DTE Energy Co (DTE):石油・ガス:M&Aディール及び事業提携情報
    Summary DTE Energy Company (DTE Energy) is a diversified energy company that develops and manages energy-related businesses and services. It has presence in the electricity value chain from generation, procurement, to transmission, distribution, and sales. The company procures, stores, and transport …
  • Netmedia S.A.:企業の戦略・SWOT・財務分析
    Netmedia S.A. - Strategy, SWOT and Corporate Finance Report Summary Netmedia S.A. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate …
  • Bankinter, S.A.:企業のM&A・事業提携・投資動向
    Bankinter, S.A. - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report Summary Marketline's Bankinter, S.A. Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments report includes business description, detailed reports on mergers and acquisitions (M&A), divestm …

◆H&Iグローバルリサーチ株式会社のお客様(例)◆